Doximity, Inc. Class A Common Stock (DOCS)
54.29
-8.29 (-13.25%)
NYSE · Last Trade: Nov 7th, 5:48 PM EST
Detailed Quote
| Previous Close | 62.58 |
|---|---|
| Open | 56.54 |
| Bid | 54.30 |
| Ask | 54.68 |
| Day's Range | 53.35 - 58.24 |
| 52 Week Range | 41.82 - 85.21 |
| Volume | 5,709,348 |
| Market Cap | 10.05B |
| PE Ratio (TTM) | 46.40 |
| EPS (TTM) | 1.2 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 1,275,041 |
Chart
About Doximity, Inc. Class A Common Stock (DOCS)
Doximity Inc is a digital platform designed specifically for medical professionals, primarily physicians, to enhance communication and collaboration within the healthcare community. The platform provides a range of tools and resources, including secure messaging, telehealth services, and access to a network of healthcare professionals, allowing doctors to connect with each other and stay updated on medical news and developments. Additionally, Doximity offers features such as electronic faxing, a comprehensive directory of healthcare providers, and opportunities for continuing medical education, all aimed at improving clinical workflows and ultimately enhancing patient care. Read More
News & Press Releases
Risk-off sentiment dominated Wall Street on Friday, with selling pressure in AI-linked names intensifying and pushing technology stocks toward their worst week since April.
Via Benzinga · November 7, 2025
Medical professional network Doximity (NYSE:DOCS) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 23.2% year on year to $168.5 million. The company expects next quarter’s revenue to be around $180.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.45 per share was 18.7% above analysts’ consensus estimates.
Via StockStory · November 7, 2025
Medical professional network Doximity (NYSE:DOCS) announced better-than-expected revenue in Q3 CY2025, with sales up 23.2% year on year to $168.5 million. The company expects next quarter’s revenue to be around $180.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.45 per share was 18.7% above analysts’ consensus estimates.
Via StockStory · November 6, 2025
Doximity (DOCS) beat Q2 FY2026 earnings and revenue estimates, but shares fell on cautious future guidance. Revenue grew 23% YoY.
Via Chartmill · November 6, 2025
Via Benzinga · November 6, 2025
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, 2025.
By Doximity · Via Business Wire · November 6, 2025
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto markets.
Via Benzinga · November 6, 2025
Medical professional network Doximity (NYSE:DOCS) will be announcing earnings results this Thursday after market close. Here’s what you need to know.
Via StockStory · November 4, 2025
Businesses with strong free cash flow tend to be more adaptable and resilient.
Some of these companies shine bright by using their cash wisely to strengthen their market positions.
Via StockStory · November 2, 2025
Shares of medical professional network Doximity (NYSE:DOCS) jumped 5.2% in the afternoon session after Bank of America Securities upgraded its rating on the stock from 'Neutral' to 'Buy'.
Via StockStory · October 27, 2025
Via Benzinga · October 27, 2025
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Doximity Inc. (NYSE: DOCS) breached their fiduciary duties to shareholders.
By Halper Sadeh LLC · Via Business Wire · October 24, 2025
A number of stocks fell in the afternoon session after reports revealed the Trump administration is considering new restrictions on software exports to China.
Via StockStory · October 22, 2025
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal second quarter ended September 30, 2025 after market close on November 6, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
By Doximity · Via Business Wire · October 16, 2025
Wall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Via StockStory · October 14, 2025
A number of stocks jumped in the afternoon session after President Donald Trump eased concerns over escalating trade tensions with China, calming markets rattled by his earlier tariff threats.
Via StockStory · October 13, 2025
Doximity trades at $64.99 per share and has stayed right on track with the overall market, gaining 23.6% over the last six months. At the same time, the S&P 500 has returned 21.1%.
Via StockStory · October 13, 2025
Shares of medical professional network Doximity (NYSE:DOCS) fell 6.7% in the morning session after JP Morgan downgraded the stock to 'Underweight' from 'Neutral', citing concerns about its high valuation and uncertainty in advertising trends.
Via StockStory · October 10, 2025
Via Benzinga · October 10, 2025
Doximity (DOCS) shows strong growth, high profitability, and a positive technical setup, making it a notable stock for growth-focused investors.
Via Chartmill · October 10, 2025
A number of stocks jumped in the afternoon session after confidence in the artificial intelligence market was renewed, pushing both the S&P 500 and Nasdaq to new all-time intraday highs.
Via StockStory · October 8, 2025
A number of stocks fell in the afternoon session after markets pulled back as a report raised concerns about artificial intelligence demand and profitability.
Via StockStory · October 7, 2025
Discover Doximity (DOCS), a stock with strong earnings growth and a bullish technical chart pattern, offering a potential entry point for momentum investors.
Via Chartmill · October 7, 2025
A cash-heavy balance sheet is often a sign of strength, but not always.
Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
Via StockStory · October 6, 2025
